Health Open Orphan founder says Covid-19 ‘is over’Cathal Friel, the head of the pharma firm, has contradicted official advice to isolate, and says the virus should now be treated like a cold or flu
Companies Open Orphan swings to profit for the first time after ‘milestone year’ for the firmRevenue at the pharmaceutical services company increased almost 80 per cent last year after it secured a number of large contracts
Shares in Poolbeg Pharma begin trading on the US venture marketInfectious disease pharmaceutical hopes dual listing in US and London improves liquidity in its shares
Poolbeg Pharma lands deal with AI firm to pinpoint effective virus drugsUS giant OneThree Biotech will lend Open Orphan spinout its state-of-the-art technology to accelerate treatment of severe respiratory infection RSV
Luke O’Neill joins Open Orphan spin-off ahead of pharma firm’s IPOAmbitions are high for Poolbeg Pharma, which will develop drugs to fight infectious diseases
